ARS Wealth Advisors Group
ABBV icon

ARS Wealth Advisors Group’s AbbVie ABBV Stock Holding History

ARS Wealth Advisors Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.45M Buy
9,358
+9
+0.1% +$2.31K 0.18% 64
2026
Q2 		$2.35M Buy
9,349
+1,604
+21% +$345K 0.18% 63
2026
Q1 		$1.68M Buy
7,745
+5
+0.1% +$1.11K 0.14% 69
2025
Q4 		$1.77M Buy
7,740
+2
+0% +$456 0.16% 61
2025
Q3 		$1.79M Buy
7,738
+285
+4% +$58K 0.18% 60
2025
Q2 		$1.38M Buy
7,453
+202
+3% +$37.5K 0.16% 64
2025
Q1 		$1.52M Sell
7,251
-22
-0.3% -$4.28K 0.21% 54
2024
Q4 		$1.29M Buy
7,273
+905
+14% +$166K 0.18% 56
2024
Q3 		$1.26M Buy
6,368
+261
+4% +$48.7K 0.15% 60
2024
Q2 		$1.05M Buy
6,107
+568
+10% +$94.1K 0.14% 65
2024
Q1 		$1.01M Sell
5,539
-192
-3% -$33.1K 0.14% 67
2023
Q4 		$888K Sell
5,731
-3,619
-39% -$528K 0.13% 69
2023
Q3 		$1.39M Buy
9,350
+3,819
+69% +$561K 0.23% 56
2023
Q2 		$745K Buy
5,531
+1,466
+36% +$215K 0.12% 78
2023
Q1 		$648K Sell
4,065
-26
-0.6% -$3.98K 0.12% 73
2022
Q4 		$661K Sell
4,091
-95
-2% -$14.6K 0.11% 77
2022
Q3 		$562K Buy
4,186
+1
+0% +$143 0.09% 90
2022
Q2 		$641K Sell
4,185
-208
-5% -$31.8K 0.09% 94
2022
Q1 		$712K Sell
4,393
-324
-7% -$47.1K 0.12% 64
2021
Q4 		$639K Buy
4,717
+25
+0.5% +$2.95K 0.11% 76
2021
Q3 		$506K Buy
+4,692
New +$536K 0.09% 79

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

ARS Wealth Advisors Group's ABBV Position: Q3 2026 in Review

ARS Wealth Advisors Group increased its AbbVie (ABBV) stake by 0.1% in Q3 2026, buying an estimated $2.31K and bringing the position to 9,358 shares worth $2.45M. The position accounts for 0.18% of the portfolio, ranked #64.

ARS Wealth Advisors Group first reported a position in ABBV in Q3 2021 and has held it in 21 quarters since. 1,792 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • ARS Wealth Advisors Group held 9,358 shares of AbbVie worth $2.45M as of Q3 2026.
  • ARS Wealth Advisors Group bought 9 AbbVie shares in Q3 2026, an estimated $2.31K.
  • AbbVie made up 0.18% of ARS Wealth Advisors Group's portfolio in Q3 2026, its #64 holding.
  • ARS Wealth Advisors Group first reported a position in AbbVie in Q3 2021 and has held it in 21 quarters since.
  • 1,792 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q3 2026, filed 16 Oct 2026.